Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
academic, accomplish, adhere, Alexion, analytical, AOCI, appeal, AstraZeneca, attainment, attention, Bay, bulletin, calendar, capable, certainty, cGMP, chemistry, Chief, civil, COBRA, Code, compliant, compromised, confidence, conserve, core, crossing, deficiency, description, deterred, difficult, difficulty, discovering, discovery, Dr, East, electronic, employment, ensuring, entail, equivalent, exempt, exhausted, Fontenot, formulation, Francisco, GMP, Head, inconclusive, inspection, insurance, interpretation, interruption, Jason, jeopardized, labor, leave, liable, light, lump, Mark, McClung, media, mediated, monthly, morale, November, oral, OTC, overhead, packaging, panel, passed, perception, Pink, preemption, President, primate, produce, produced, profile, purport, reallocate, reallocation, recall, reclassified, regain, reliant, restore, Richmond, Rule, San, scale, seizure, senior, shortage, showcasing, speculative, split, strictly, sum, suspension, syndrome, talent, talented, team, text, turnover, unchanged, undermine, undocumented, unlisted, UNREGISTERED, variation, Vice, vitro
Removed:
approximated, assured, autoimmune, balanced, beginning, beta, Bioverativ, bowel, building, capacity, CAR, collaborative, collection, concentrated, delayed, divestiture, editing, female, flexibility, genome, harmed, Huntington, inflammatory, irrevocable, jointly, launched, male, manufactured, NKR, originally, partnership, past, perpetual, primary, proposed, recovered, recruiting, recruitment, repay, researching, reverted, screening, shortened, sickle, strong, TCR, thalassemia, titled, travel, ZFN
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view